Chronic idiopathic myelofibrosis expressing a novel type of TEL-PDGFRB chimaera responded to imatinib mesylate therapy. [electronic resource]
Producer: 20070209Description: 190-2 p. digitalISSN:- 0887-6924
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Benzamides
- Chromosomes, Human, Pair 12
- Chromosomes, Human, Pair 5
- Chronic Disease
- Fatal Outcome
- Humans
- Imatinib Mesylate
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Oncogene Proteins, Fusion -- biosynthesis
- Piperazines -- therapeutic use
- Primary Myelofibrosis -- complications
- Pyrimidines -- therapeutic use
- Transcription, Genetic
- Translocation, Genetic
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.